BTAI - BioXcel Therapeutics, Inc.
IEX Last Trade
0.3696
0.005 1.218%
Share volume: 6,095
Last Updated: Thu 26 Dec 2024 08:29:19 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$0.37
0.00
1.23%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-14 | 2023-03-16 | 2023-05-09 | 2023-08-14 | 2023-11-14 | 2024-03-22 | 2024-05-09 | |
| Total revenue | 0.000 | 137.000 K | 238.000 K | 206.000 K | 457.000 K | 341.000 K | 376.000 K | 582.000 K | |
| Cost of revenue | 0.000 | 11.000 K | 9.000 K | 9.000 K | 26.000 K | 512.000 K | 713.000 K | 80.000 K | |
| Gross profit | 0.000 | 126.000 K | 229.000 K | 197.000 K | 431.000 K | -171.000 K | -337.000 K | 502.000 K | |
| inf% | 81.75% | -13.97% | 118.78% | -139.68% | -97.08% | 248.96% | |||
| Operating expenses | 36.288 M | 39.116 M | 53.116 M | 51.395 M | 52.845 M | 43.963 M | 19.536 M | 24.665 M | |
| Selling general and admin | 18.382 M | 17.054 M | 20.404 M | 23.595 M | 25.872 M | 24.344 M | 9.602 M | 13.264 M | |
| Research and development | 17.906 M | 22.062 M | 32.712 M | 27.800 M | 26.973 M | 19.619 M | 9.934 M | 11.401 M | |
| Total expenses | 36.288 M | 39.127 M | 53.125 M | 51.404 M | 52.871 M | 44.475 M | 20.249 M | 24.745 M | |
| 7.82% | 35.78% | -3.24% | 2.85% | -15.88% | -54.47% | 22.20% | |||
| Operating income | -36.288 M | -38.990 M | -52.887 M | -51.198 M | -52.414 M | -44.134 M | -19.873 M | -24.163 M | |
| Ebit | -36.288 M | -38.990 M | -52.887 M | -51.198 M | -52.414 M | -44.134 M | -19.873 M | -24.163 M | |
| Pretax income | -37.670 M | -41.805 M | -54.810 M | -52.796 M | -53.515 M | -50.486 M | -22.256 M | -26.791 M | |
| 10.98% | 31.11% | -3.67% | 1.36% | -5.66% | -55.92% | 20.38% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -37.670 M | -41.805 M | -54.810 M | -52.796 M | -53.515 M | -50.486 M | -22.256 M | -26.791 M | |
| -10.98% | -31.11% | 3.67% | -1.36% | 5.66% | 55.92% | -20.38% | |||
| Net income | -37.670 M | -41.805 M | -54.810 M | -52.796 M | -53.515 M | -50.486 M | -22.256 M | -26.791 M | |
| -10.98% | -31.11% | 3.67% | -1.36% | 5.66% | 55.92% | -20.38% |